CEFUROXIME PANPHARMA 1.5g powder intravenous infusible solution medication leaflet

J01DC02 cefuroxime • Antiinfectives for systemic use | Other beta-lactam antibacterials | Second-generation cephalosporins

Cefuroxime is a second-generation cephalosporin antibiotic used to treat moderate bacterial infections. It is indicated for upper respiratory tract infections (such as sinusitis, tonsillitis, or pharyngitis), lower respiratory tract infections (bronchitis, pneumonia), urinary tract infections, otitis media, skin and soft tissue infections, as well as some bone and joint infections.

Cefuroxime works by inhibiting bacterial cell wall synthesis, killing the bacteria responsible for the infection. It is available in tablet, oral suspension, or injectable solution form.

Side effects may include nausea, diarrhea, abdominal pain, skin rashes, or allergic reactions. In rare cases, it can cause pseudomembranous colitis or severe hypersensitivity reactions. It is contraindicated in patients with allergies to cephalosporins or penicillins.

General data about CEFUROXIME PANPHARMA 1.5g

Substance: cefuroxime

Date of last drug list: 01-07-2013

Commercial code: W08581004

Concentration: 1.5g

Pharmaceutical form: powder intravenous infusible solution

Quantity: 100

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Concentrations available for cefuroxime

1.5g, 125mg, 125mg/5ml, 1500mg, 250mg, 250mg/5ml, 500mg, 50mg, 750mg

Other substances similar to cefuroxime